ducovest

FDTS:NSD-First Trust Developed Markets ex-US Small Cap AlphaDEX® Fund (USD)

ETF | Foreign Small/Mid Value |

Last Closing

USD 43.8

Change

+0.48 (+1.11)%

Market Cap

USD 8.89M

Volume

9.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to select stocks from the NASDAQ Developed Markets Ex-US Index that may generate positive alpha, or risk-adjusted returns, relative to traditional indices through the use of the AlphaDEX® selection methodology.

Company Website : http://www.ftportfolios.com/

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Foreign Small/Mid Value

ETFs Containing FDTS

N/A

Market Performance

  Market Performance vs. Industry/Classification (Foreign Small/Mid Value) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 8.34% 50% F 64% D
Dividend Return 0.88% 50% F 21% F
Total Return 9.21% 50% F 63% D
Trailing 12 Months  
Capital Gain 15.74% 50% F 62% D
Dividend Return 1.93% 50% F 29% F
Total Return 17.67% 50% F 61% D-
Trailing 5 Years  
Capital Gain 24.40% 50% F 61% D-
Dividend Return 14.10% 50% F 57% F
Total Return 38.50% 50% F 62% D
Average Annual (5 Year Horizon)  
Capital Gain 6.93% N/A N/A 61% D-
Dividend Return 9.78% N/A N/A 63% D
Total Return 2.85% N/A N/A 61% D-
Risk Return Profile  
Volatility (Standard Deviation) 23.08% N/A N/A 72% C
Risk Adjusted Return 42.38% N/A N/A 72% C
Market Capitalization 8.89M 50% F 11% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.